Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
BlackRock, Inc. reported a 8.10% stake in Vanda Pharmaceuticals Inc. (Schedule 13G/A)
Event Jan 31, 2025 · Filed Feb 7, 2025
BlackRock, Inc. reported a 8.10% stake in Vanda Pharmaceuticals Inc., 4,699,280 shares, as a passive investor on Jan 31, 2025. Filed Feb 7, 2025 (Schedule 13G/A).
- Stake
- 8.10%
- Shares
- 4,699,280
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.10% | 4,699,280 |
Source
Related
- Vanda Pharmaceuticals Inc.
- BlackRock, Inc.
- Vanda Pharmaceuticals Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026